Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem
Author:
Funder
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Link
http://link.springer.com/content/pdf/10.1007/s40264-019-00849-8.pdf
Reference41 articles.
1. Avorn J. Powerful medicines: the benefits, risks, and costs of prescription drugs. New York: Alfred A. Knopf; 2004.
2. Dal Pan GJ. Communicating the risks of medicines: time to move forward. Med Care. 2012;50(6):463–5.
3. Downing NS, Aminawung JA, Shah ND, Krumholz HM, Ross JS. Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005–2012. JAMA. 2014;311(4):368–77.
4. Avorn J. In defense of pharmacoepidemiology: embracing the yin and yang of drug research. N Engl J Med. 2007;357(22):2219–21.
5. Giner L, Nichols CM, Zalsman G, Oquendo MA. Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: an update. Int J Adolesc Med Health. 2005;17(3):211–20.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action;Heliyon;2024-08
2. Enhancing readability of USFDA patient communications through large language models: a proof-of-concept study;Expert Review of Clinical Pharmacology;2024-06-04
3. Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance;Drug Safety;2023-05-23
4. Language choice in official information materials on COVID-19 in the Philippines: a language justice perspective;International Journal of Multilingualism;2022-12-31
5. Radical transparency in post-market oversight of medicine safety;BMJ;2022-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3